Beta Bionics (BBNX) shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.
Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.
The stock debuted on the Nasdaq Global Market under the "BBNX" ticker.
The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.
The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.
Price: 23.28, Change: +6.28, Percent Change: +36.91
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。